Search results

Keywords: zwierz��cy model choroby Parkinsona

Change search criteria ↓

No projects match the keywords exactly — showing projects with similar words.

1. Effect of various types of acute exercise and exercise trening on NO/sGC/cGMP pathway and death of dopaminergic neurons …

Principal investigator: prof. Małgorzata Chalimoniuk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 1, Panel: NZ5
2. Spatial analysis of the effects of L-DOPA on gene expression in the prefrontal cortex in a mouse model of Parkinson's di…

Principal investigator: dr Anna Aleksandra Radlicka-Borysewska

Instytut Farmakologii PAN

Call: PRELUDIUM 19, Panel: NZ4
3. The role of sphingosine-1-phosphate (S1P) receptors signaling in animal model of Parkinson disease. Searching of novel t…

Principal investigator: Joanna Agata Motyl

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: PRELUDIUM 5, Panel: NZ4
4. Normal021falsefalsefalseMicrosoftInternetExplorer4/* Style Definitions */table.MsoNormalTable{mso-style-name:Standardowy…

Principal investigator: dr Anna Gąsiorowska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: SONATA 1, Panel: NZ7
5. Modeling Progression of α-Synucleinopathy in Noradrenergic and Serotonergic Systems – Possible Link with Prodromal Sympt…

Principal investigator: Anna Hajam Alwani

Instytut Farmakologii PAN

Call: PRELUDIUM 23, Panel: NZ4
6. Effect of Urolithin A on gut microbiota and intestinal integrity contributing to neuroprotective effects in a model of P…

Principal investigator: Olga Wojciechowska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: PRELUDIUM 23, Panel: NZ7
7. Evaluation of P2X7 purinergic receptor as a trigger of brain metabolic abnormalities and neuronal degeneration in a mous…

Principal investigator: dr Anna Wilkaniec

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: SONATA BIS 13, Panel: NZ4
8. Urolithin A as a metabolite of ellagitannins with potential neuroprotective activity - the research of mechanisms of thi…

Principal investigator: dr Małgorzata Kujawska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: SONATA 13, Panel: NZ7
9. Znaczenie kinazy sfingozyny 1 oraz sfingozyno-1-fosforanu w doświadczalnym modelu choroby Parkinsona oraz w farmakologic…

Principal investigator: Joanna Agata Motyl

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: ETIUDA 4, Panel: NZ3
10. The research of molecular markers for neuroprotective effect of tetrahydroisoquinolines based on various eksperimental m…

Principal investigator: dr Agnieszka Wąsik

Instytut Farmakologii PAN

Call: OPUS 4, Panel: NZ7
11. Modulation of mitochondrial calcium traffic in pink1 mutant Zebrafish model of Parkinson's disease

Principal investigator: dr Smijin Karthully Soman

Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

Call: SONATA 8, Panel: NZ3
12. The mechanisms of mitochondrial damage-dependent neuroinflammation in experimental models of Parkinson's disease. The ro…

Principal investigator: prof. Agata Adamczyk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 20 (LAP), Panel: NZ4
13. The importance of the crosstalk between alpha-synuclein and sphingosine-1-phosphate-dependent signalling in experimental…

Principal investigator: dr Joanna Agata Motyl

Instytut Biocybernetyki i Inżynierii Biomedycznej im. Macieja Nałęcza PAN

Call: SONATINA 3, Panel: NZ4
14. Involvement of astrocytes in the neuroprotective mechanism evoked by enhancement of noradrenergic transmission in trasng…

Principal investigator: Justyna Beata Barut

Instytut Farmakologii PAN

Call: PRELUDIUM 18, Panel: NZ7

Projects search

Search results